PamGene Licenses Tech to Innogenetics for Diagnostic Tests | GenomeWeb

NEW YORK, May 27 (GenomeWeb News) - PamGene has exclusively licensed its microarray technology to Innogenetics for development of multiple-parameter nucleic acid-and protein diagnostics in the area of infectious diseases, genetic testing and neurodegeneration, the companies said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.